Claims for Patent: 11,654,196
✉ Email this page to a colleague
Summary for Patent: 11,654,196
| Title: | Dosing regimens for echinocandin class compounds |
| Abstract: | The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds. |
| Inventor(s): | Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy |
| Assignee: | NAPP PHARMACEUTICAL GROUP Ltd , Seachaid Pharmaceuticals LLC |
| Application Number: | US16/920,316 |
| Patent Claims: |
1. A method of treating or preventing a fungal infection in a subject, the method comprising administering to the subject by intravenous infusion an aqueous solution comprising from 0.50 mg/mL to 3 mg/mL of compound 22 having the structure: or a pharmaceutically acceptable salt thereof. 2. A method of treating or preventing a fungal infection in a subject, the method comprising administering to the subject by intravenous bolus an aqueous solution comprising from 25 mg/mL to 500 mg/mL of compound 22 having the structure: or a pharmaceutically acceptable salt thereof. 3. A device for injecting into a subject an aqueous solution comprising compound 22 having the structure: or a pharmaceutically acceptable salt thereof, wherein the device comprises a container holding from 0.05 mL to 10 mL of said aqueous solution and a needle. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
